Geneos Wealth Management Inc. Cuts Holdings in Morgan Stanley $MS

Geneos Wealth Management Inc. lessened its stake in Morgan Stanley (NYSE:MS) by 93.9% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 4,500 shares of the financial services provider’s stock after selling 69,042 shares during the quarter. Geneos Wealth Management Inc.’s holdings in Morgan Stanley were worth $741,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in MS. Purpose Unlimited Inc. purchased a new stake in shares of Morgan Stanley during the fourth quarter worth approximately $25,000. Motiv8 Investments LLC purchased a new position in Morgan Stanley in the fourth quarter worth approximately $25,000. Olistico Wealth LLC purchased a new position in Morgan Stanley in the fourth quarter worth approximately $27,000. Lodestone Wealth Management LLC acquired a new position in Morgan Stanley during the 4th quarter worth approximately $28,000. Finally, WFA of San Diego LLC purchased a new stake in shares of Morgan Stanley in the 2nd quarter valued at approximately $28,000. 84.19% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on MS shares. HSBC raised their price objective on shares of Morgan Stanley from $153.00 to $177.00 and gave the company a “hold” rating in a report on Friday, April 17th. JPMorgan Chase & Co. increased their target price on Morgan Stanley from $187.00 to $195.00 and gave the company a “neutral” rating in a report on Thursday. Wells Fargo & Company raised their price target on Morgan Stanley from $225.00 to $240.00 and gave the company an “equal weight” rating in a research note on Thursday. BNP Paribas Exane lifted their price target on Morgan Stanley from $195.00 to $205.00 and gave the stock a “neutral” rating in a report on Friday, April 24th. Finally, Royal Bank Of Canada reaffirmed a “sector perform” rating and set a $207.00 price objective on shares of Morgan Stanley in a research report on Thursday, April 16th. Two analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating, eleven have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Morgan Stanley presently has an average rating of “Moderate Buy” and a consensus price target of $220.80.

Morgan Stanley News Summary

Here are the key news stories impacting Morgan Stanley this week:

• Positive Sentiment: Morgan Stanley reported blockbuster Q2 2026 results, with record net revenues of about $21.3 billion and earnings that beat expectations, reinforcing confidence in the company’s core businesses. Morgan Stanley (MS) Q2 2026 Earnings Call Highlights: Record Revenues and Strategic Growth …
• Positive Sentiment: The board declared a quarterly dividend of $1.15 per share, a 15% increase from the prior quarter, which signals confidence in earnings power and capital return capacity.
• Positive Sentiment: Analysts turned more constructive after the earnings release, with Keefe, Bruyette & Woods raising its price target to $250 and Erste Group lifting FY2027 EPS estimates, suggesting more upside may remain. Morgan Stanley had its price target raised by Keefe, Bruyette & Woods from $225.00 to $250.00
• Neutral Sentiment: New reports also pointed to Morgan Stanley’s E*TRADE crypto rollout and AI-related market activity, which could help broaden its platform appeal over time but are not likely the main short-term drivers of the stock move.
• Negative Sentiment: Some articles noted a downgrade-style view from Seeking Alpha and a JPMorgan target below the current share price, which may temper enthusiasm at the margin even after the strong earnings beat. Morgan Stanley Maintains Hold on Comstock Resources, Keeps Price Target Unchanged at $16 Amid Cash Outspend and Funding Concerns

Morgan Stanley Price Performance

Shares of MS opened at $215.27 on Monday. Morgan Stanley has a 1-year low of $136.17 and a 1-year high of $232.25. The stock has a market cap of $339.54 billion, a PE ratio of 17.40, a price-to-earnings-growth ratio of 1.56 and a beta of 1.23. The company has a debt-to-equity ratio of 3.52, a current ratio of 0.77 and a quick ratio of 0.77. The firm has a fifty day moving average price of $211.69 and a 200 day moving average price of $188.77.

Morgan Stanley (NYSE:MS) last issued its quarterly earnings data on Wednesday, July 15th. The financial services provider reported $3.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.89 by $0.57. Morgan Stanley had a return on equity of 19.51% and a net margin of 15.65%.The company had revenue of $21.35 billion for the quarter, compared to analyst estimates of $19.67 billion. During the same quarter last year, the company posted $2.13 earnings per share. The business’s quarterly revenue was up 27.1% compared to the same quarter last year. As a group, sell-side analysts anticipate that Morgan Stanley will post 12.55 EPS for the current year.

Morgan Stanley Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Friday, July 31st will be given a $1.15 dividend. This is a boost from Morgan Stanley’s previous quarterly dividend of $1.00. The ex-dividend date of this dividend is Friday, July 31st. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.1%. Morgan Stanley’s payout ratio is currently 32.34%.

Morgan Stanley announced that its Board of Directors has authorized a share buyback plan on Wednesday, June 24th that permits the company to repurchase $20.00 billion in shares. This repurchase authorization permits the financial services provider to buy up to 5.6% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s management believes its shares are undervalued.

About Morgan Stanley

Morgan Stanley (NYSE: MS) is a global financial services firm headquartered in New York City. Founded in 1935 by Henry S. Morgan and Harold Stanley, the company provides a broad range of investment banking, securities, wealth management and investment management services to corporations, governments, institutions and individual investors. Leadership has been guided by a senior executive team and board of directors; James P. Gorman has served as the company’s chief executive and chairman in recent years.

The firm’s primary business activities are organized around three principal businesses: Institutional Securities, Wealth Management and Investment Management.